2176P Serum levels of galectin-9 predict the survival of patients with gastric and gastroesophageal junction adenocarcinoma.
Saved in:
| Title: | 2176P Serum levels of galectin-9 predict the survival of patients with gastric and gastroesophageal junction adenocarcinoma. |
|---|---|
| Authors: | Digomann, D.1 (AUTHOR), Reiche, C.1 (AUTHOR), Stammberger, A.2 (AUTHOR), Willms, T.1 (AUTHOR), Rudek, L.3 (AUTHOR), Grabenkamp, A.3 (AUTHOR), Klimova, A.4 (AUTHOR), Merboth, F.1 (AUTHOR), Natusch, L.1 (AUTHOR), Schmitz, M.2 (AUTHOR), Bruns, C.3 (AUTHOR), Schloesser, H.3 (AUTHOR), Weitz, J.1 (AUTHOR), Seifert, L.1 (AUTHOR), Seifert, A.M.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1217-S1217. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!